Moderna Inc. (NASDAQ: MRNA) Q3 2020 earnings call dated Oct. 29, 2020 Corporate Participants: Lavina Talukdar -- Senior Vice President & Head of Investor
Moderna Inc. (MRNA) Q3 2020 Earnings Call Transcript
Categories
Health Care
Moderna reports higher earnings, wider loss in Q3
Moderna Inc (NASDAQ: MRNA) reported third-quarter 2020 financial results before the opening bell on Thursday. The frontrunner in COVID vaccine research reported
Amgen Inc. (AMGN) Q3 2020 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q3 2020 earnings call dated Oct. 28, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert A. Bradway -- Chairman
Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report
Biopharmaceutical company Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also exceeded the
Centene Corp. (CNC) Q3 2020 Earnings Call Transcript
Centene Corp. (NYSE: CNC) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Jennifer Gilligan -- Senior Vice President, Finance & Investor Relations
Eli Lilly and Company (LLY) Q3 2020 Earnings Call Transcript
Eli Lilly and Company (NYSE : LLY) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Kevin Hern -- Vice President, Investor Relations
Pfizer Inc (PFE) Q3 2020 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q3 2020 Earnings Call dated Oct. 27, 2020. Corporate Participants: Chuck Triano -- Senior Vice President, Investor Relations Albert Bourla -- Chairman
Laboratory Corp Of America Holdings (LH) Q3 2020 Earnings Call Transcript
Laboratory Corp Of America Holdings (NYSE: LH) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Clarissa Willett -- Vice President, Investor Relations
Merck & Co. Inc. (MRK) Q3 2020 Earnings Call Transcript
Merck & Co. Inc. (NYSE: MRK) Q3 2020 earnings call dated Oct. 27, 2020 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Kenneth
Pfizer (PFE) posts mixed results in Q3
Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a 4% decline
Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report
Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The company's stock
Trxade Group Inc. (MEDS) Q3 2020 Earnings Call Transcript
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 earnings call dated Oct. 26, 2020 Corporate Participants: Howard Doss -- Chief Financial Officer Suren Ajjarapu -- Chief Executive
Trxade (MEDS) delivers another quarter of strong revenue growth
Trxade (NASDAQ: MEDS) on Monday posted a 174% increase in third-quarter revenues to $6.3 million, riding on continued strength in PPE sales.
Quest Diagnostics, Inc. (DGX) Q3 2020 Earnings Call Transcript
Quest Diagnostics, Inc. (NYSE: DGX) Q3 2020 earnings call dated Oct. 22, 2020 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen
Edwards Lifesciences Corp (EW) Q3 2020 Earnings Call Transcript
Edwards Lifesciences Corp (NYSE: EW) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Mark Wilterding -- Investor Relations Michael A. Mussallem -- Chairman and
Align Technology Inc. (ALGN) Q3 2020 Earnings Call Transcript
Align Technology Inc (NASDAQ: ALGN) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Shirley Stacy -- Vice President - Finance, Corporate and
Abbott Laboratories (ABT) Q3 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and
Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript
Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara -- Head of Investor Relations Michel Vounatsos -- Chief Executive Officer
Thermo Fisher Scientific Inc (TMO) Q3 2020 Earnings Call Transcript
Thermo Fisher Scientific Inc (NYSE: TMO) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Kenneth J. Apicerno -- Vice President, Investor Relations
ABT Earnings: Key numbers from Abbott Laboratories Q3 financial results
Abbott (NYSE: ABT) today announced its third quarter financial results for the period ended September 30, 2020. Net earnings for the third
Biogen tops market estimates in Q3, lowers guidance
Biogen (NASDAQ: BIIB) reported third-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 6% decline in